image
PMV Pharmaceuticals, Inc. PMVP
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.9027
-7.34 %
$ 46.9 M
Market Cap
-0.76
P/E
BALANCE SHEET
191 M ASSETS
-24.14%
Growth Rates
1Year -24.14%
3Years -16.75%
5Years 13.17%
7Years 0.00%
10Years 0.00%
15.2 M LIABILITIES
-42.53%
Growth Rates
1Year -42.53%
3Years -12.89%
5Years -38.55%
7Years 0.00%
10Years 0.00%
176 M EQUITY
-21.98%
Growth Rates
1Year -21.98%
3Years -17.05%
5Years 35.09%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet PMV Pharmaceuticals, Inc.
image
Current Assets 176 M
Cash & Short-Term Investments 169 M
Receivables 0
Other Current Assets 6.2 M
Non-Current Assets 15.6 M
Long-Term Investments 13.8 M
PP&E 1.55 M
Other Non-Current Assets 235 K
88.59 %3.24 %7.24 %Total Assets$191.3m
Current Liabilities 14.4 M
Accounts Payable 6.58 M
Short-Term Debt 352 K
Other Current Liabilities 7.44 M
Non-Current Liabilities 838 K
Long-Term Debt 0
Other Non-Current Liabilities 838 K
43.26 %48.92 %5.51 %Total Liabilities$15.2m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 40.9 37.7 108.3 172.5 361.4 73.3 30.3
Short Term Investments 128.6 165.4 132.8 124.7 0 28.2 31.6
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 6.2 4.4 6.0 4.1 6.7 0.6 0.3
Total Current Assets 175.7 207.4 247.0 301.3 364.8 102.1 62.2
PP&E 1.6 19.0 20.5 13.2 0.6 0.7 1.0
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 13.8 25.5 2.5 16.9 0 0 0
Other Long Term Assets 0.2 0.2 0.3 0.2 0.2 0.2 0.2
Other Assets 0 0 0 0 0 0 0
Total Assets 191.3 252.2 270.3 331.6 365.5 103.0 63.5
LIABILITIES
Accounts Payable 6.6 3.2 3.0 3.2 1.6 2.8 1.0
Short Term Debt 0.4 0.9 1.1 0.8 0 0 0
Other Current Liabilities 7.4 9.9 6.8 8.2 4.8 1.7 1.3
Total Current Liabilities 14.4 14.0 10.8 12.2 6.4 4.5 2.3
Long Term Debt 0 12.4 13.4 10.8 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0.6 0.2 1.4 7.5 2.5 3.5 0.2 0.2 0.4 0.7 1.5 2.0 2.0 1.2 1.4 0.4 19 K 19 K 0 0 0
Total Liabilities 5.6 6.2 7.2 17.4 6.3 7.4 6.6 6.3 6.2 13.5 13.6 14.2 10.7 10.2 11.1 4.4 6.1 2.9 4.2 1.1 1.1
EQUITY
Common Stock 10 K 10 K 10 K 10 K 4 K 3 K 5 K 4 K 19 K 5 K 22 K 18 K 15 K 12 K 11 K 11 K 11 K 9 K 4 K 4 K 3 K
Retained Earnings (91.5) (89.6) (80.1) (82.3) (73.6) (71.5) (61.8) (54.2) (52.4) (44.4) (27.5) (21.3) (17.7) (16.8) (16.0) (15.6) (16.4) (6.1) (4.2) (2.7) (2.2)
Other Accumulative Comprehensive Income/Loss (0.3) (0.2) (0.2) (0.4) (0.4) (0.3) (0.4) (0.3) (0.4) (0.4) (0.3) (0.2) (0.2) (0.1) (0.1) (0.1) 99 K 18 K 0 0 0
Total Equity 10.0 11.5 20.4 17.6 4.4 3.8 4.4 11.3 11.5 5.7 19.9 22.7 23.0 21.2 20.7 19.9 18.2 22.9 5.6 5.6 3.9
Total Liabilities and Equity 15.6 17.6 27.5 35.0 10.7 11.2 11.0 17.6 17.7 19.2 33.6 37.0 33.7 31.4 31.7 24.3 24.3 25.8 9.8 6.7 5.0
SHARES OUTSTANDING
Common Shares Outstanding 10.4 10.4 10.2 5.9 3.6 1.2 84.5 K 82.9 K 37.9 K 17.4 K 15.8 K 12.4 K 10.5 K 9.75 K 8.95 K 8.81 K 7.58 K 4.23 K 3.24 K 3.04 K 2.42 K